Good news, bad news: rAAA deaths down, but 43% occur in people that don’t qualify for screening
EPIDEMIOLOGY OF FATAL RUPTURED AORTIC ANEURYSMS IN THE UNITED STATES (1999-2016). Journal of Vascular Surgery, February 2019.
EPIDEMIOLOGY OF FATAL RUPTURED AORTIC ANEURYSMS IN THE UNITED STATES (1999-2016). Journal of Vascular Surgery, February 2019.
A recent finding published in the Journal of Vascular Surgery concludes that people with peripheral (or leg) artery disease and depression are more likely than other patients to face amputation and death due to their disease.
AUTHORS OFFER TIPS FOR BEST LONG-TERM CLINICAL OUTCOMES FOR TREATMENT OF CHRONIC ILIOFEMORAL VENOUS OBSTRUCTION
The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI) recently notched yet another milestone when it welcomed its 500th participating center to the registry. Now, with 513 centers, 500,000 procedures, and 3,000 participating physicians entering cases across 12 different vascular procedures, the VQI has experienced significant growth since its inception in 2011.
A new study finds that a significant percentage of cancer patients are not getting any care for their lymphedema, leading to a notable treatment gap.
The Chicago-based Society for Vascular Surgery has announced it will relocate its headquarters to Rosemont, Ill., near Chicago’s O’Hare International Airport, as of March 1, 2019. The SVS is an international, not-for-profit professional medical society, serving specialty-trained vascular surgeons and allied professionals.
INSULIN-DEPENDENT PATIENTS MAY HAVE WORSE VASCULAR SURGICAL OUTCOMES
Researchers from Johns Hopkins University have found that obese patients were more likely to have longer procedures and to lose more blood than those who were not obese, and obese patients were more likely to have post-operative problems such as renal failure or wound infections.
Recent advances in statins and other medications have led some researchers to suggest that surgical treatments for carotid stenosis should be limited to symptomatic patients – primarily those who have already had a stroke or TIA. However, a new study published in the Journal of Vascular Surgery questions whether medical therapy is a sufficient stroke-reduction strategy. In the study, only 35 percent of stroke patients were receiving both statin and antiplatelet agents prior to their event, suggesting that asymptomatic carotid disease is unrecognized in many individuals, noted lead researcher Dr. W. Darrin Clouse of Massachusetts General Hospital. “And the first manifestation of their disease,” he wrote, “could be the occurrence of a stroke.”